Live

Watch CBSN Live

Martin Shkreli: EpiPen cost is "really quite a bargain"

In a conversation with CBS News' Vinita Nair, controversial former CEO of Turing Pharmaceuticals defends drug-maker Mylan for its skyrocketing cost of the device that delivers a life-saving injection for people with severe allergies. Shkreli has no connection with the EpiPen product. He also claims he is "innocent" of his own, unrelated federal securities fraud charges.
View CBS News In
CBS News App Open
Chrome Safari Continue